ABOUT

Meet our team

A cross-functional team of scientists, clinicians and drug developers relentlessly pursuing treatments for inherited channelopathies, cardiometabolic diseases and cardiomyopathies.

Leadership

Paul F. Truex, MBA
Chairman of the Board & Chief Executive Officer

Read biography →

Debra Odink, PhD
President & Chief Development Officer

Read biography →

Amy Sehnert, MD, FACC
Chief Medical Officer

Read biography →

Matt Killeen, PhD
Chief Business Officer

Read biography →

Saumya Das, MD, PhD
Chief Scientific Advisor


Read biography →

Aidan McNeil, JD, BCL
Senior Vice President, Administration & Associate General Counsel

Read biography →

Team

Dinesh Srinivasan, PhD
Vice President, Strategic Portfolio Management

Read biography →

Alexandre Brkovic, PhD
Vice President, Clinical Research

Read biography →

Ashley Prasse Miller, MSc
Vice President, Clinical Operations


Read biography →

Marc Vidal, PhD
Vice President, Chemistry


Read biography →

Curtis McGrath, CPA
Vice President, Finance


Read biography →

Jennifer L. Strande, MD, PhD
Executive Director, Clinical Development


Read biography →

Justine Keller
Director, Finance


Read biography →

Delphine Labit, MSc
Director, Research


Read biography →

Alicia Schiavi, MSc
Associate Director, Clinical Operations

Read biography →

Maroua Khalifa, PhD
Associate Director, Pharmaceutical Development

Read biography →

Sabindra Pradhananga, PhD
Associate Director, Non-Clinical Development


Read biography →

Julie Vatté, PhD
Research Scientist

Read biography →

Kayluz Frias Boligan, PhD
Research Scientist

Read biography →

Brittany Hagen
Manager, Communications

Read biography →

Shannon Hewgill, MSc
Research Associate

Read biography →

Wenxia Luo, PhD
Postdoctoral Researcher, Dmpk

Read biography →

Philippe Beauclair, PhD
Postdoctoral Researcher, Chemistry

Read biography →

Cuihan Zhou, PhD
Postdoctoral Researcher, Chemistry

Read biography →